168 related articles for article (PubMed ID: 16636243)
1. Mycophenolate mofetil in dermatomyositis: is it safe?
Rowin J; Amato AA; Deisher N; Cursio J; Meriggioli MN
Neurology; 2006 Apr; 66(8):1245-7. PubMed ID: 16636243
[TBL] [Abstract][Full Text] [Related]
2. Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate.
Waldman MA; Callen JP
J Am Acad Dermatol; 2004 Aug; 51(2 Suppl):S124-30. PubMed ID: 15280831
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
4. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of relapsing polychondritis with mycophenolate mofetil.
Goldenberg G; Sangueza OP; Jorizzo JL
J Dermatolog Treat; 2006; 17(3):158-9. PubMed ID: 16854756
[TBL] [Abstract][Full Text] [Related]
6. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.
Gelber AC; Nousari HC; Wigley FM
J Rheumatol; 2000 Jun; 27(6):1542-5. PubMed ID: 10852287
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.
Edge JC; Outland JD; Dempsey JR; Callen JP
Arch Dermatol; 2006 Jan; 142(1):65-9. PubMed ID: 16415388
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
[No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Ogimi C; Honma N; Tanaka R; Oh-ishi T
Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
[TBL] [Abstract][Full Text] [Related]
12. [Cryptococcal disease and immunosuppressive treatment].
Riera-Mestre A; de la Haba-Vacas I; Vidaller-Palacín A; Fernández-Viladrich P
Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):595. PubMed ID: 17125686
[No Abstract] [Full Text] [Related]
13. Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.
Jones EA
Hepatology; 2002 Feb; 35(2):258-62. PubMed ID: 11826397
[No Abstract] [Full Text] [Related]
14. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Wang A; Smith JR; Creevy KE
J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
[TBL] [Abstract][Full Text] [Related]
15. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
Zimmerman AB; Berger EM; Elmariah SB; Soter NA
J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA
Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
[TBL] [Abstract][Full Text] [Related]
18. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
[TBL] [Abstract][Full Text] [Related]
19. A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.
Akyol M; Ozçelik S; Engin A; Ozel l ahin G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1447-8. PubMed ID: 17958877
[No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
Hayashi M; Kikuchi T; Takada T
Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
